Case-Based Roundtable Meetings Spotlight: April 2 2022

Rini Compares Upfront Immune-Based Regimens for Renal Cell Carcinoma

April 30, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Brian Rini, MD, discussed the choice of treatment options including dual immunotherapy and tyrosine kinase inhibitors plus immunotherapy for a patient with stage IV clear cell renal cell carcinoma.

Yazbeck Considers the Use of New Approaches in Relapsed/Refractory DLBCL

April 29, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Victor Yazbeck, MD, MS, discussed the data from recent clinical trials of tafasitamab/lenalidomide, polatuzumab vedotin, and loncastuximab tesirine for patients with relapsed/refractory diffuse large B-cell lymphoma.

Roundtable Discussion: Exploring CDK Inhibition in HR+, HER2– Early-Stage Breast Cancer

April 25, 2022

Clinical Articles

During a case-based roundtable event, Kevin Kalinsky, MD, MS, discussed clinical typing of patients with breast cancer and the results of trials of therapies for patients with HR-positive, HER2-negative breast cancer.